Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
published in: Investigational New Drugs
date of publication: 2013-11-01
main subject: colorectal cancer, bevacizumab, oxaliplatin, metastatic colon cancer, dasatinib monohydrate, capecitabine, dasatinib
Cites articles 31
- 2004-06
Date
Title
Article - wd:Q33940893